Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2021

01-08-2021 | Positron Emission Tomography | Original Article

Body weight-dependent Rubidium-82 activity results in constant image quality in myocardial perfusion imaging with PET

Authors: J. D. van Dijk, MSc, PhD, M. Dotinga, BSc, P. L. Jager, MD, PhD, C. H. Slump, PhD, JP Ottervanger, MD, PhD, M. Mouden, MD, PhD, J. A. van Dalen, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2021

Login to get access

Abstract

Background

Clinical practice shows degrading image quality in heavier patients who undergo myocardial perfusion imaging (MPI) with Rubidium-82 (Rb-82) PET when using a fixed tracer activity. Our aim was to derive and validate a patient-specific activity protocol resulting in a constant image quality in PET MPI.

Methods

We included 251 patients who underwent rest MPI with Rb-82 PET (Discovery 670, GE Healthcare). 132 patients were included retrospectively and were scanned using a fixed activity of 740 MBq. The total number of measured prompts was normalized to activity and correlated to body weight, mass per body length and body mass index to find the best predicting parameter. Next, a patient-specific activity was derived and subsequently validated in 119 additional patients. Image quality was scored by three experts on a four-point scale.

Results

Both image quality and prompts decreased in heavier patients when using a fixed activity (p < .005). Body weight was used to derive a new activity formula: Activity = 8.3 MBq/kg. When applying this formula, both measured prompts and scored image quality became independent of body weight (p > .60).

Conclusion

Administrating a Rb-82 activity that linearly depends on body weight resulted in a constant image quality across all patients and is recommended.
Appendix
Available only for authorised users
Literature
1.
go back to reference DeKemp RA, Yoshinaga K, Beanlands RSB. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 2007;14:380-97.CrossRef DeKemp RA, Yoshinaga K, Beanlands RSB. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 2007;14:380-97.CrossRef
2.
go back to reference Sciagrà R, Passeri A, Bucerius J, Verberne HJ, Slart RHJA, Lindner O, et al. Clinical use of quantitative cardiac perfusion PET: Rationale, modalities and possible indications. Position paper of the cardiovascular committee of the European association of nuclear medicine (EANM). Eur J Nucl Med Mol Imaging 2016;43:1530-45.CrossRef Sciagrà R, Passeri A, Bucerius J, Verberne HJ, Slart RHJA, Lindner O, et al. Clinical use of quantitative cardiac perfusion PET: Rationale, modalities and possible indications. Position paper of the cardiovascular committee of the European association of nuclear medicine (EANM). Eur J Nucl Med Mol Imaging 2016;43:1530-45.CrossRef
3.
go back to reference Mc Ardle BA, Dowsley TF, DeKemp RA, Wells GA, Beanlands RS. Does Rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol 2012;60:1828-37.CrossRef Mc Ardle BA, Dowsley TF, DeKemp RA, Wells GA, Beanlands RS. Does Rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol 2012;60:1828-37.CrossRef
4.
go back to reference Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJW, et al. Does quantification of myocardial flow reserve using Rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2012;19:670-80.CrossRef Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJW, et al. Does quantification of myocardial flow reserve using Rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol 2012;19:670-80.CrossRef
5.
go back to reference Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Cardiol 2018;25:269-97.CrossRef Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Cardiol 2018;25:269-97.CrossRef
6.
go back to reference Desiderio MC, Lundbye JB, Baker WL, Farrell MB, Jerome SD, Heller GV. Current status of patient radiation exposure of cardiac positron emission tomography and single-photon emission computed tomographic myocardial perfusion imaging. Circ Cardiovasc Imaging 2018;11:e007565.CrossRef Desiderio MC, Lundbye JB, Baker WL, Farrell MB, Jerome SD, Heller GV. Current status of patient radiation exposure of cardiac positron emission tomography and single-photon emission computed tomographic myocardial perfusion imaging. Circ Cardiovasc Imaging 2018;11:e007565.CrossRef
7.
go back to reference Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;54:1485-507.CrossRef Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;54:1485-507.CrossRef
8.
go back to reference Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226.CrossRef Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226.CrossRef
9.
go back to reference Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, et al. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med 2005;46:603-7.PubMed Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, et al. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med 2005;46:603-7.PubMed
10.
go back to reference Schelbert HR, Beanlands R, Bengel F, Knuuti J, DiCarli M, Machac J, et al. PET myocardial perfusion and glucose metabolism imaging: Part 2: Guidelines for interpretation and reporting. J Nucl Cardiol 2003;10:557-71.CrossRef Schelbert HR, Beanlands R, Bengel F, Knuuti J, DiCarli M, Machac J, et al. PET myocardial perfusion and glucose metabolism imaging: Part 2: Guidelines for interpretation and reporting. J Nucl Cardiol 2003;10:557-71.CrossRef
11.
go back to reference Case JA, DeKemp RA, Slomka PJ, Smith MF, Heller GV, Cerqueira MD. Status of cardiovascular PET radiation exposure and strategies for reduction: An information statement from the cardiovascular PET task force. J Nucl Cardiol 2017;24:1427-39.CrossRef Case JA, DeKemp RA, Slomka PJ, Smith MF, Heller GV, Cerqueira MD. Status of cardiovascular PET radiation exposure and strategies for reduction: An information statement from the cardiovascular PET task force. J Nucl Cardiol 2017;24:1427-39.CrossRef
12.
go back to reference Huizing ED, Van Dijk JD, van Dalen JA, Timmer JR, Arkies H, Slump CH, et al. Minimizing Rubidium-82 tracer activity for relative PET myocardial perfusion imaging. Nucl Med Commun 2017;38:708-14.CrossRef Huizing ED, Van Dijk JD, van Dalen JA, Timmer JR, Arkies H, Slump CH, et al. Minimizing Rubidium-82 tracer activity for relative PET myocardial perfusion imaging. Nucl Med Commun 2017;38:708-14.CrossRef
13.
go back to reference Moody JB, Hiller KM, Lee BC, Corbett JR, Ficaro EP, Murthy VL. Limitations of Rb-82 weight-adjusted dosing accuracy at low doses. J Nucl Cardiol 2016;24:1395-401.CrossRef Moody JB, Hiller KM, Lee BC, Corbett JR, Ficaro EP, Murthy VL. Limitations of Rb-82 weight-adjusted dosing accuracy at low doses. J Nucl Cardiol 2016;24:1395-401.CrossRef
15.
go back to reference Renaud JM, Yip K, Guimond J, Trottier M, Pibarot P, Turcotte E, et al. Characterization of 3-dimensional PET systems for accurate quantification of myocardial blood flow. J Nucl Med 2017;58:103-9.CrossRef Renaud JM, Yip K, Guimond J, Trottier M, Pibarot P, Turcotte E, et al. Characterization of 3-dimensional PET systems for accurate quantification of myocardial blood flow. J Nucl Med 2017;58:103-9.CrossRef
17.
go back to reference Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, et al. Clinical Interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI. J Nucl Med 2014;55:58-64.CrossRef Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, et al. Clinical Interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI. J Nucl Med 2014;55:58-64.CrossRef
18.
go back to reference Groves AM, Speechly-Dick ME, Dickson JC, Kayani I, Endozo R, Blanchard P, et al. Cardiac 82 rubidium PET/CT: Initial European experience. Eur J Nucl Med Mol Imaging 2007;34:1965-72.CrossRef Groves AM, Speechly-Dick ME, Dickson JC, Kayani I, Endozo R, Blanchard P, et al. Cardiac 82 rubidium PET/CT: Initial European experience. Eur J Nucl Med Mol Imaging 2007;34:1965-72.CrossRef
19.
go back to reference Van Dijk JD, Jager PL, Mouden M, Slump CH, Ottervanger JP, de Boer J, et al. Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT. J Nucl Cardiol 2014;21:1158-67.CrossRef Van Dijk JD, Jager PL, Mouden M, Slump CH, Ottervanger JP, de Boer J, et al. Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using CZT-SPECT. J Nucl Cardiol 2014;21:1158-67.CrossRef
20.
go back to reference Van Dijk JD, Jager PL, Ottervanger JP, de Boer J, Oostdijk AHJ, Engbers EM, et al. Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using conventional SPECT. J Nucl Cardiol 2016;23:134-42.CrossRef Van Dijk JD, Jager PL, Ottervanger JP, de Boer J, Oostdijk AHJ, Engbers EM, et al. Development and validation of a patient-tailored dose regime in myocardial perfusion imaging using conventional SPECT. J Nucl Cardiol 2016;23:134-42.CrossRef
21.
go back to reference de Groot EH, Post N, Boellaard R, Wagenaar NR, Willemsen AT, van Dalen JA. Optimized dose regimen for whole-body FDG-PET imaging. EJNMMI Res 2013;3:63-74.CrossRef de Groot EH, Post N, Boellaard R, Wagenaar NR, Willemsen AT, van Dalen JA. Optimized dose regimen for whole-body FDG-PET imaging. EJNMMI Res 2013;3:63-74.CrossRef
Metadata
Title
Body weight-dependent Rubidium-82 activity results in constant image quality in myocardial perfusion imaging with PET
Authors
J. D. van Dijk, MSc, PhD
M. Dotinga, BSc
P. L. Jager, MD, PhD
C. H. Slump, PhD
JP Ottervanger, MD, PhD
M. Mouden, MD, PhD
J. A. van Dalen, PhD
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-019-01875-w

Other articles of this Issue 4/2021

Journal of Nuclear Cardiology 4/2021 Go to the issue